Management of shock associated with Dengue haemorrhagic fever based on pathophysiological findings.
D000818:Animals; D000937:Antigen-Antibody Reactions; D001344:Autopsy; D001784:Blood Gas Analysis; D002319:Cardiovascular System / Q000473:pathology; D003176:Complement C3 / Q000378:metabolism; D003181:Complement C4 / Q000378:metabolism; D003165:Complement System Proteins / Q000172:deficiency; D003715:Dengue / Q000150:complications* / Q000276:immunology / Q000473:pathology; D004211:Disseminated Intravascular Coagulation / Q000503:physiopathology; D004573:Electrolytes / Q000097:blood; D006439:Hemodynamics; D006801:Humans; D006967:Hypersensitivity; D007964:Leukocytosis; D008253:Macaca mulatta; D011517:Prothrombin Time; D012769:Shock / Q000209:etiology* / Q000628:therapy; D013921:Thrombocytopenia
D003176:Complement C3; D003181:Complement C4; D004573:Electrolytes; D003165:Complement System Proteins